TP53 and cancer: Only a single patient possessed the protective genotype, reported to be associated with later cancer onset in germline TP53 mutation carriers [10] (0 at risk loci shown in Table 4), and although patients with less favorable genotypes appeared to be slightly younger at cancer diagnosis, these differences were not statistically significant (P = 0.78).